Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Free Cash Flow (2016 - 2025)

AtriCure (ATRC) has disclosed Free Cash Flow for 16 consecutive years, with $26.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 690.52% to $26.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $56.1 million, a 7426.44% increase, with the full-year FY2025 number at $56.1 million, up 7426.44% from a year prior.
  • Free Cash Flow was $26.2 million for Q4 2025 at AtriCure, up from $20.2 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $26.2 million in Q4 2025 to a low of -$26.2 million in Q1 2022.
  • A 5-year average of $276000.0 and a median of -$3.1 million in 2022 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: crashed 357.56% in 2022, then soared 690.52% in 2025.
  • AtriCure's Free Cash Flow stood at $5.8 million in 2021, then plummeted by 357.56% to -$14.9 million in 2022, then surged by 179.2% to $11.8 million in 2023, then crashed by 137.57% to -$4.4 million in 2024, then skyrocketed by 690.52% to $26.2 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Free Cash Flow are $26.2 million (Q4 2025), $20.2 million (Q3 2025), and $21.9 million (Q2 2025).